Advertisement
Singapore markets closed
  • Straits Times Index

    3,297.55
    -26.98 (-0.81%)
     
  • Nikkei

    38,814.56
    +94.09 (+0.24%)
     
  • Hang Seng

    17,941.78
    -170.85 (-0.94%)
     
  • FTSE 100

    8,146.86
    -16.81 (-0.21%)
     
  • Bitcoin USD

    66,264.20
    -572.66 (-0.86%)
     
  • CMC Crypto 200

    1,403.06
    -14.81 (-1.04%)
     
  • S&P 500

    5,431.60
    -2.14 (-0.04%)
     
  • Dow

    38,589.16
    -57.94 (-0.15%)
     
  • Nasdaq

    17,688.88
    +21.32 (+0.12%)
     
  • Gold

    2,348.40
    +30.40 (+1.31%)
     
  • Crude Oil

    78.49
    -0.13 (-0.17%)
     
  • 10-Yr Bond

    4.2130
    -0.0250 (-0.59%)
     
  • FTSE Bursa Malaysia

    1,607.32
    -2.85 (-0.18%)
     
  • Jakarta Composite Index

    6,734.83
    -96.73 (-1.42%)
     
  • PSE Index

    6,383.70
    -7.13 (-0.11%)
     

Top Glove Corporation Bhd Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Top Glove Corporation Bhd (KLSE:TOPGLOV) Second Quarter 2024 Results

Key Financial Results

  • Revenue: RM550.3m (down 11% from 2Q 2023).

  • Net loss: RM39.6m (loss narrowed by 76% from 2Q 2023).

  • RM0.006 loss per share (improved from RM0.021 loss in 2Q 2023).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Top Glove Corporation Bhd EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 10%. Earnings per share (EPS) exceeded analyst estimates by 3.6%.

Looking ahead, revenue is forecast to grow 33% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Medical Equipment industry in Asia.

ADVERTISEMENT

Performance of the market in Malaysia.

The company's shares are down 1.2% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on Top Glove Corporation Bhd's balance sheet health.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.